Differential expression of the TGF‐β isoforms in embryogenesis suggests specific roles in developing and adult tissues
Authors:
- 1 June 1992
- journal article
- review article
- Published by Wiley in Molecular Reproduction and Development
- Vol. 32 (2) , 91-98
Abstract
The TGF‐β's are multifunctional, pleiotropic molecules with major effects in control of cellular migration, cellular proliferation, and elaboration of extracellular matrix. Thus far, five distinct isoforms of TGF‐β have been described, each approximately 65–85% homologous and containing the characteristic 9 positionally conserved cysteine residues. Although the actions of the activated mature forms of the different isoforms on cells are qualitatively similar in most cases, there are a few examples of distinct activities. For example, TGF‐β's 1 and 3, but not TGF‐β2, inhibit the growth of large vessel endothelial cells, and TGF‐β's 2 and 3, but not TGF‐β1, inhibit the survival of cultured embryonic chick ciliary ganglionic neurons. In addition, selective targeting of the latent forms of the TGF‐β's is suggested by the observation that latent TGF‐β2 is the prominent isoform found in body fluids such as amniotic fluid, breast milk, and the aqueous and vitreous humor of the eye; it is noteworthy in this regard that TGF‐β2 is unique among various isoforms in that it lacks a RGD integrin‐binding sequence in its precursor. The most dramatic differences in the TGF‐β isoforms are seen at the level of expression, where there is now a wealth of data demonstrating both spatially and temporally distinct expression of both the mRNAs and proteins in developing tissues, regenerating tissues, and in pathologic responses. Moreover, the post‐transcriptional regulation of TGF‐β expression by members of the steroid/retinoid family of nuclear receptors is also isoform‐specific; thus, treatment of keratinocytes with retinoids induces secretion of TGF‐β2, whereas treatment of breast cancer cells with gestodene, a synthetic progestin, induces secretion of TGF‐β1. Recent characterization of the 5′ regulatory regions of the human TGF‐β 1, 2, and 3 genes suggests that distinct features of the promoters, including the presence of TATAA boxes and transcription factor binding sites, form the basis for the observed differential transcription.Keywords
This publication has 26 references indexed in Scilit:
- Differential regulation of the expression of transforming growth factor‐β mRNAs by growth factors and retinoic acid in chicken embryo chondrocytes, myocytes, and fibroblastsJournal of Cellular Physiology, 1992
- The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta.Journal of Clinical Investigation, 1991
- Molecular Cloning and Structure of the Human Transforming Growth Factor-β2 Gene PromoterGrowth Factors, 1991
- Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1Nature, 1990
- Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur.Journal of Cell Biology, 1990
- Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation.Journal of Experimental Medicine, 1989
- Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice.Journal of Cell Biology, 1989
- Transforming Growth Factor Beta-1 in Acute Myocardial Infarction in RatsGrowth Factors, 1988
- Role of transforming growth factor-beta in the development of the mouse embryo.Journal of Cell Biology, 1987
- Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cellsNature, 1985